Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PAR | Ann: June 2025 Quarterly Activities Report & Appendix 4C | 20:27 | 9 | 2.4K | |||
|
|||||||
| PAR | Sharewise Presentation 22/7/24 | 18:44 | 142 | 48K | |||
|
|||||||
| PAR | The Phase III Primer! | 17:46 | 24 | 6.0K | |||
|
|||||||
| PAR | Ann: Paradigm Investor Webinar | 13:17 | 11 | 4.2K | |||
|
|||||||
| PAR | Ann: Paradigm Secures US$27M to Advance Phase 3 OA Trial | 10:07 | 133 | 46K | |||
|
|||||||
| PAR | Phase 3 Trial progress | 28/07/25 | 38 | 16K | |||
|
|||||||
| PAR | research reports and media | 28/07/25 | 4.6K | 2.2M | |||
|
|||||||
| PAR | Chart | 25/07/25 | 4.9K | 4.1M | |||
|
|||||||
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $158.9M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 38.5¢ | $305.4K | 773.9K |
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2196 | 39.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 6365 | 2 |
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
|
|||||
|
Last
39.5¢ |
Change
0.000 ( 2.47 %) |
||||
| Open | High | Low | Volume | ||
| 40.0¢ | 40.5¢ | 38.5¢ | 144513 | ||
| Last updated 15.59pm 29/07/2025 ? | |||||
| PAR (ASX) Chart |
